Latest valuation
MXL$71.92LLY$1390.82SOFI$21.58QRVO$91.93ADM$91.38CTVA$98.60CF$141.71AMBA$99.77PATH$17.79BBY$87.04DELL$442.53DLTR$126.34IBM$326.92UNH$417.99CRM$320.75HPQ$23.55SNOW$303.57SNPS$632.92MRVL$238.26MOS$29.78
Equity Valuation Research

Current Fair Value Assessments

Moving beyond speculative target prices, our AI-driven framework introduces the world's only Point-in-Time valuation logic. By analyzing fundamentals through multi-scenario volatile combinations, we deliver outcomes mapped to specific timelines, completely reshaping how value is defined.

06/02/2026 10:32:15 AM ET
$71.92Target Price
MXL Valuation Report 2026-06-02

MXL Valuation Report 2026-06-02Hot

MaxLinear is strategically transitioning from broadband connectivity to higher-margin AI infrastructure solutions, focusing on optical interconnects for hyperscale data centers. While maintaining a base revenue stream, the company is prioritizing technological differentiation and premium market segments to drive gross margin expansion. Recent partnerships with Edgecore Networks and GCT Semiconductor, alongside the Panther platform for AI data centers, signal this shift, supported by positive analyst ratings anticipating substantial earnings growth by 2028. MaxLinear’s financial performance is influenced by macroeconomic factors – stable interest rates and modest GDP growth – but mitigated by a focus on resilient AI demand. Management has evolved from cost-cutting to aggressive growth strategies, prioritizing R&D and strategic wins. Key risks include geopolitical tensions impacting supply chains, competitive pressures, and reliance on key customers. Despite volatility, the company demonstrates improving liquidity and a commitment to innovation, positioning it for potential outperformance within the expanding AI ecosystem, though sustained execution and navigating cyclical headwinds remain critical.

MXL
06/02/2026 9:40:07 AM ET
$1390.82Target Price
LLY Valuation Report 2026-06-02

LLY Valuation Report 2026-06-02Hot

Eli Lilly is a fully integrated pharmaceutical company experiencing accelerated growth, recently exceeding a $1 trillion market capitalization driven by strong uptake of its GLP-1 drugs, Zepbound and Mounjaro, and expanding insurance coverage. While currently benefiting from established franchises in diabetes and oncology, the company is diversifying its portfolio through acquisitions in vaccine development and infectious diseases, and continued investment in areas like oncology and cardiometabolic disease. Financially, Lilly is robust with strong margins and manageable debt, supporting continued R&D and acquisitions. Strategic shifts over the past four quarters demonstrate a focus on capital allocation towards R&D, manufacturing expansion, and operational efficiency. Risk factors include competitive pressures within the GLP-1 market, regulatory challenges, and successful integration of acquired assets. Macroeconomic conditions present both opportunities – stable GDP growth – and challenges – persistent inflation. Recent balance sheet adjustments show increased leverage balanced by strong cash flow, and a strategic emphasis on shareholder returns. While R&D investment lags industry averages, the company demonstrates improving cash flow and a focus on long-term growth, though volatility in key metrics warrants continued monitoring.

LLY
06/02/2026 8:20:00 AM ET
$21.58Target Price
SOFI Valuation Report 2026-06-02

SOFI Valuation Report 2026-06-02

SoFi Technologies is a diversified financial technology company focused on lending and integrated financial solutions, expanding into areas like embedded finance and brokerage through platforms like Galileo and Technisys. Revenue growth exceeds 20% annually, driven by increased membership and product offerings, though performance is marked by cyclical volatility and a widening gap between share price and fundamentals. Strategic priorities include scaling loan origination, reducing costs via technology, cross-selling products, and expanding into digital assets with a U.S. dollar stablecoin. Recent shifts in capital allocation prioritize platform scaling and international expansion. While demonstrating operational improvements and a broadening economic moat, SoFi faces challenges including intense fintech competition, managing capital intensity, navigating evolving credit scoring methodologies, and macroeconomic pressures like inflation and interest rate fluctuations. The company is focused on enhancing member experience, driving innovation, and achieving sustained profitability through operational efficiency and diversified revenue streams, with a recent emphasis on AI and blockchain integration. Financial analysis reveals a complex balance sheet with fluctuating capital adequacy ratios and a need for disciplined cost management to support long-term value creation.

SOFI
06/01/2026 11:40:32 PM ET
$91.93Target Price
QRVO Valuation Report 2026-06-01

QRVO Valuation Report 2026-06-01

Qorvo develops RF systems for mobile, infrastructure, and defense, balancing cyclical smartphone revenue with higher-margin specialized products. The company is strategically shifting towards infrastructure, defense, and automotive (particularly via silicon carbide technology) to drive long-term growth, despite recent resilience amidst smartphone market headwinds. A pending acquisition by Skyworks introduces risk but potential synergies. Valuation currently suggests a potential re-rating if strategic initiatives succeed. Key focuses include margin improvement, efficient cost management, and maintaining a healthy cash conversion cycle. While benefiting from indirect exposure to AI infrastructure build-out, Qorvo faces intense RF sector competition. Recent financial performance shows improved profitability and a declining net debt position. Macroeconomic stability supports demand, though inflationary pressures remain a concern. The merger with Skyworks is a pivotal event, requiring successful integration to realize anticipated benefits. Strategic evolution over the past four quarters has focused on operational efficiency, portfolio optimization, and capital allocation, with a growing emphasis on R&D and high-growth areas.

QRVO
06/01/2026 5:05:30 PM ET
$91.38Target Price
ADM Valuation Report 2026-06-01

ADM Valuation Report 2026-06-01

Archer Daniels Midland (ADM) navigates a complex landscape of cyclical commodity prices, geopolitical risks, and evolving consumer preferences. The company focuses on optimizing existing operations – targeting $500M in savings by 2029 – while investing in “second curve” growth areas like nutrition, biosolutions, and sustainability initiatives, including carbon capture. Recent performance shows stabilization following pressures from crop pricing, with biofuel demand driving earnings recovery and upwardly revised guidance. ADM’s diversified structure mitigates some risk, but performance remains sensitive to global production and macroeconomic conditions. Strategic acquisitions, like Flock, aim to enhance logistics and expand service offerings. Financial performance reveals fluctuating revenue and margins, with a downward trend since 2022, though recent stabilization is noted. Capital allocation prioritizes share buybacks and strategic investments, with a focus on maintaining liquidity. While ADM demonstrates operational flexibility, challenges remain in consistently achieving higher ROIC and maintaining margins above industry averages. Valuation metrics suggest potential near-term correction, followed by moderate long-term appreciation contingent on successful execution of strategic initiatives and favorable market conditions. Ongoing risks include escalating geopolitical tensions, commodity price volatility, and the need for robust risk management.

ADM
06/01/2026 4:40:08 PM ET
$98.60Target Price
CTVA Valuation Report 2026-06-01

CTVA Valuation Report 2026-06-01

Corteva, Inc. (CTVA) is a fully integrated agricultural inputs provider focused on seed and crop protection, leveraging intellectual property for premium pricing and expanding into digital solutions for recurring revenue. Recent Q1 2026 results exceeded expectations due to seed/crop protection demand and cost optimization, with full-year guidance reaffirmed. A strategic separation into Corteva (crop protection) and Vylor (advanced seed/genetics) is planned for late 2026 to unlock shareholder value, with Vylor positioned as an innovation leader. Key considerations include working capital management, maintaining investment-grade credit ratings, and navigating cyclical market pressures. Valuation is supported by differentiated technology but requires monitoring competitive dynamics and regulatory landscapes. Management has focused on operational efficiency and long-term value creation through restructuring programs. Risks include PFAS litigation, regulatory hurdles, and supply chain volatility. Recent performance demonstrates top-line growth driven by pricing power and regional diversification, alongside a commitment to capital allocation and shareholder returns. Successful execution of the separation and sustained innovation will be crucial for long-term growth.

CTVA
06/01/2026 12:33:33 PM ET
$141.71Target Price
CF Valuation Report 2026-06-01

CF Valuation Report 2026-06-01

CF Industries Holdings is a vertically integrated producer of nitrogen and hydrogen products, serving agriculture, industry, and energy sectors. Revenue is driven by nitrogen fertilizer prices and volumes, heavily influenced by natural gas costs and agricultural cycles. The company benefits from North American scale and a robust distribution network. Recent Q1 2026 earnings reached $615 million, boosted by strong nitrogen demand and geopolitical supply constraints, though normalization is expected. CF maintains a strong financial position with $2.04 billion in cash and is investing in low-carbon ammonia production. While facing cyclicality and potential pricing pressures, its diversified portfolio and strategic investments aim to support competitiveness. Macroeconomic factors, including stable GDP, persistent inflation, and a steady labor market, present both opportunities and challenges. The company’s capital allocation strategy has become increasingly aggressive, prioritizing decarbonization and operational restructuring. Risks include commodity price volatility, operational disruptions, regulatory changes, and geopolitical instability. Over the past four quarters, CF has demonstrated a strategic evolution characterized by an increasingly aggressive approach towards capital allocation, operational guidance, and organizational restructuring. The company’s revenue trajectory exhibits pronounced volatility with a discernible upward trend over the five-year horizon.

CF
05/30/2026 6:47:18 PM ET
$99.77Target Price
AMBA Valuation Report 2026-05-30

AMBA Valuation Report 2026-05-30

Ambarella is a fabless semiconductor company transitioning from consumer electronics to automotive and edge AI, seeking higher margins. Revenue grew 16.9% recently, driven by automotive, but guidance suggests near-term deceleration. A significant $800M+ agreement with Hanwha focuses on robotics and AI, while a $50M share repurchase program signals confidence. The company faces capital intensity, cyclical automotive risks, and competition in edge AI. Strategic shifts prioritize R&D and partnerships, with a focus on influencing analyst perceptions. Macroeconomic factors—modest GDP growth, stable unemployment, and inflation—present challenges to demand and costs. Ambarella’s financial performance shows volatile revenue, moderate growth, high gross margins offset by substantial R&D investment, and a recent improvement in cash flow. Risk factors include customer concentration (70% through Wingtech), supply chain dependencies, and technological obsolescence. The company aims for ‘second curve’ growth through innovation and securing design wins, but faces challenges in maintaining intangible asset value and achieving consistent profitability. Valuation suggests a moderate dispersion around $67, with a current trading price of $72.18 and a projected long-term target of $99.77.

AMBA
05/30/2026 6:43:45 PM ET
$17.79Target Price
PATH Valuation Report 2026-05-30

PATH Valuation Report 2026-05-30

UiPath is a software company specializing in robotic process automation (RPA) and increasingly, AI-driven business orchestration. Revenue is driven by annual recurring subscriptions and related services, currently at $1.901 billion (12% YoY growth) fueled by agentic AI adoption. While recent earnings met expectations, the focus is on scaling enterprise deals and leveraging AI integration for higher contract values. Gross margins remain strong (82%+) despite significant operating expenses. Strategically, UiPath is expanding geographically, exemplified by a collaboration with Microsoft Korea, and prioritizing AI capabilities. Despite positive developments, the stock faces short interest, indicating investor skepticism. Recent financial performance shows stabilization, with a focus on ARR growth and robust gross margins. Over the past year, capital allocation prioritized AI innovation and operational efficiency, with a consistent emphasis on ARR and a shift towards agentic automation. Risks include tax liabilities, macroeconomic volatility, and competition. However, the company demonstrates strong revenue per employee and a growing asset-light ratio, suggesting efficient operations. Valuation indicates a moderate dispersion, with a long-term target price around $17.79, contingent on successful execution and favorable market conditions.

PATH
05/30/2026 5:37:32 PM ET
$87.04Target Price
BBY Valuation Report 2026-05-30

BBY Valuation Report 2026-05-30

Best Buy operates as a multi-channel retailer of consumer electronics and appliances, with revenue from hardware, software, warranties, and services. Recent performance shows stabilization and a potential recovery, driven by a 2% comparable sales increase and margin expansion in Q1 FY27, particularly in gaming and computing offsetting appliance weakness. EPS rose 11% year-over-year to $1.28, indicating operational leverage despite inflation. Positive market reaction and a 5% dividend yield reflect investor confidence. The company maintains moderate financial leverage and is actively returning capital to shareholders. Strategic investments in Best Buy Health and digital platforms aim to diversify revenue, but success is critical given the mature retail sector. While valuation reflects recent earnings, monitoring fundamentals is key. Macroeconomic conditions are mixed, with stable GDP/unemployment offset by persistent inflation. Over the past four quarters, Best Buy has focused on capital allocation, restructuring, and strategic initiatives like Best Buy Health. This includes share repurchases, dividend payments, and optimizing store footprint. Risk profiles have evolved, with asset impairments related to Best Buy Health and supply chain dependencies. Competitive positioning is challenged by fluctuating performance across categories, requiring focus on high-growth areas and digital capabilities. Balance sheet management prioritizes liquidity and shareholder returns, while strategic pivots aim for long-term growth and margin expansion.

BBY